BR9712794A - Compostos para e um método de inibição de metaloproteinases matriciais - Google Patents
Compostos para e um método de inibição de metaloproteinases matriciaisInfo
- Publication number
- BR9712794A BR9712794A BR9712794-9A BR9712794A BR9712794A BR 9712794 A BR9712794 A BR 9712794A BR 9712794 A BR9712794 A BR 9712794A BR 9712794 A BR9712794 A BR 9712794A
- Authority
- BR
- Brazil
- Prior art keywords
- compounds
- matrix metalloproteinases
- relates
- present
- inhibiting matrix
- Prior art date
Links
- 102000002274 Matrix Metalloproteinases Human genes 0.000 title abstract 4
- 108010000684 Matrix Metalloproteinases Proteins 0.000 title abstract 4
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 230000002401 inhibitory effect Effects 0.000 title abstract 2
- 208000037260 Atherosclerotic Plaque Diseases 0.000 abstract 1
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 206010019280 Heart failures Diseases 0.000 abstract 1
- 206010027476 Metastases Diseases 0.000 abstract 1
- 208000004210 Pressure Ulcer Diseases 0.000 abstract 1
- 208000025865 Ulcer Diseases 0.000 abstract 1
- 206010064996 Ulcerative keratitis Diseases 0.000 abstract 1
- 206010052428 Wound Diseases 0.000 abstract 1
- 208000027418 Wounds and injury Diseases 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 208000007474 aortic aneurysm Diseases 0.000 abstract 1
- 206010003246 arthritis Diseases 0.000 abstract 1
- 230000001363 autoimmune Effects 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- 230000001419 dependent effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 230000009545 invasion Effects 0.000 abstract 1
- 210000000265 leukocyte Anatomy 0.000 abstract 1
- 230000009401 metastasis Effects 0.000 abstract 1
- 201000006417 multiple sclerosis Diseases 0.000 abstract 1
- 208000028169 periodontal disease Diseases 0.000 abstract 1
- 208000037803 restenosis Diseases 0.000 abstract 1
- 231100000397 ulcer Toxicity 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/91—Dibenzofurans; Hydrogenated dibenzofurans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
- C07C311/19—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/76—Dibenzothiophenes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Vascular Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Lubricants (AREA)
- Indole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Furan Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2506396P | 1996-09-04 | 1996-09-04 | |
| US5571497P | 1997-08-07 | 1997-08-07 | |
| PCT/US1997/015444 WO1998009957A1 (en) | 1996-09-04 | 1997-09-02 | Compounds for and a method of inhibiting matrix metalloproteinases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9712794A true BR9712794A (pt) | 1999-12-14 |
Family
ID=26699217
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9712794-9A BR9712794A (pt) | 1996-09-04 | 1997-09-02 | Compostos para e um método de inibição de metaloproteinases matriciais |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6294674B1 (enExample) |
| EP (1) | EP0929542A1 (enExample) |
| JP (1) | JP2002514180A (enExample) |
| KR (1) | KR20000068415A (enExample) |
| AU (1) | AU736347B2 (enExample) |
| BR (1) | BR9712794A (enExample) |
| CA (1) | CA2256631A1 (enExample) |
| HR (1) | HRP970474B1 (enExample) |
| NZ (1) | NZ333064A (enExample) |
| WO (1) | WO1998009957A1 (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3628335B2 (ja) * | 1996-01-23 | 2005-03-09 | 塩野義製薬株式会社 | スルホン化されたアミノ酸誘導体およびそれを含有するメタロプロティナーゼ阻害剤 |
| US6919375B1 (en) | 1996-01-23 | 2005-07-19 | Shionogi & Co., Ltd. | Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same |
| MXPA99001974A (es) * | 1996-12-09 | 2002-03-27 | Warner Lambert Co | Metodo para tratar y prevenir fallas cardiacas y dilatacion ventricular. |
| WO2000006560A1 (en) * | 1998-07-30 | 2000-02-10 | Warner-Lambert Company | Tricyclic heteroaromatics and their derivatives as inhibitors of matrix metalloproteinases |
| IL140746A0 (en) * | 1998-07-30 | 2002-02-10 | Warner Lambert Co | Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| WO2000015213A1 (en) * | 1998-09-11 | 2000-03-23 | Shionogi & Co., Ltd. | Remedal or preventive agent for congestive heart failure |
| AU5101801A (en) * | 2000-03-27 | 2001-10-08 | Scripps Research Inst | Inhibition of angiogenesis and tumor growth |
| GB2365425A (en) * | 2000-08-01 | 2002-02-20 | Parke Davis & Co Ltd | Alkyl amino acid derivatives useful as pharmaceutical agents |
| US7186855B2 (en) | 2001-06-11 | 2007-03-06 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
| US6818787B2 (en) | 2001-06-11 | 2004-11-16 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
| US8048917B2 (en) | 2005-04-06 | 2011-11-01 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
| US7232924B2 (en) | 2001-06-11 | 2007-06-19 | Xenoport, Inc. | Methods for synthesis of acyloxyalkyl derivatives of GABA analogs |
| US20030129672A1 (en) * | 2001-08-29 | 2003-07-10 | Dyer Richard Dennis | Method for identifying metalloenzyme inhibitors |
| PE20030701A1 (es) | 2001-12-20 | 2003-08-21 | Schering Corp | Compuestos para el tratamiento de trastornos inflamatorios |
| ATE457716T1 (de) | 2002-12-30 | 2010-03-15 | Angiotech Int Ag | Wirkstofffreisetzung von schnell gelierender polymerzusammensetzung |
| CN1318411C (zh) * | 2005-03-21 | 2007-05-30 | 中国海洋大学 | 氢化轮枝霉酮类化合物及其制备方法和用途 |
| WO2007079199A2 (en) * | 2005-12-30 | 2007-07-12 | Alantos Pharmaceuticals, Holding, Inc. | Substituted bis-amide metalloprotease inhibitors |
| WO2008057254A2 (en) * | 2006-10-27 | 2008-05-15 | Wyeth | Tricyclic compounds as matrix metalloproteinase inhibitors |
| GB0621973D0 (en) * | 2006-11-03 | 2006-12-13 | Philogen Spa | Binding molecules and uses thereof |
| PA8779101A1 (es) * | 2007-05-04 | 2008-12-18 | Wyeth Corp | "compuestos tricíclicos como inhibidores de metaloproteinasas matriciales" |
| CN101784274A (zh) * | 2007-06-15 | 2010-07-21 | 米申制药公司 | 抑制水肿因子和腺苷酸环化酶的方法和组合物 |
| JP2012051804A (ja) * | 2008-12-26 | 2012-03-15 | Kyoto Univ | Ｅｇ５阻害剤 |
| TWI854164B (zh) | 2016-02-01 | 2024-09-01 | 美商百歐克斯製藥公司 | 苯并吡唑化合物及其類似物 |
| CN114981251B (zh) * | 2020-01-21 | 2023-11-21 | 深圳信立泰药业股份有限公司 | 一种二苯并呋喃类衍生物组织蛋白酶k抑制剂及其制备方法和医药用途 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2065966C3 (de) | 1969-09-06 | 1978-11-16 | Ajinomoto Co., Inc., Tokio | N-Fluorenyl-sulfonyl-aminocarbonsäuren sowie diese enthaltende Mittel |
| US3845097A (en) | 1969-09-06 | 1974-10-29 | Ajinomoto Kk | N-substituted amino acids and novel ester |
| US4097472A (en) | 1974-11-08 | 1978-06-27 | Mitsubishi Chemical Industries Limited | N2 -arylsulfonyl-l-argininamides and the pharmaceutically acceptable salts thereof |
| DE2236876C3 (de) * | 1971-08-19 | 1981-02-12 | Ajinomoto Co., Inc., Tokio | N-Substituierte Aminocarbonsäuren und diese Verbindungen enthaltende Arzneimittel |
| EP0183271B1 (en) * | 1984-11-30 | 1990-05-16 | Shosuke Okamoto | Lysin derivative and proteinase inhibitor |
| PH31294A (en) * | 1992-02-13 | 1998-07-06 | Thomae Gmbh Dr K | Benzimidazolyl derivatives, pharmaceutical compositions containing these compounds and process for preparing them. |
| US5455258A (en) | 1993-01-06 | 1995-10-03 | Ciba-Geigy Corporation | Arylsulfonamido-substituted hydroxamic acids |
| ES2165496T3 (es) | 1995-06-02 | 2002-03-16 | Warner Lambert Co | Inhibidores triciclicos de metaloproteinasas matriciales. |
| US5627206A (en) | 1995-06-02 | 1997-05-06 | Warner-Lambert Company | Tricyclic inhibitor of matrix metalloproteinases |
| US5665764A (en) | 1995-06-02 | 1997-09-09 | Warner-Lambert Company | Tricyclic inhibitors of matrix metalloproteinases |
| US5977141A (en) | 1995-11-17 | 1999-11-02 | Warner-Lambert Company | Sulfonamide inhibitors of matrix metalloproteinases |
| JP3628335B2 (ja) * | 1996-01-23 | 2005-03-09 | 塩野義製薬株式会社 | スルホン化されたアミノ酸誘導体およびそれを含有するメタロプロティナーゼ阻害剤 |
| AU735013B2 (en) | 1996-09-04 | 2001-06-28 | Warner-Lambert Company | Matrix metalloproteinase inhibitors and their therapeutic uses |
-
1997
- 1997-09-02 EP EP97939751A patent/EP0929542A1/en not_active Withdrawn
- 1997-09-02 CA CA002256631A patent/CA2256631A1/en not_active Abandoned
- 1997-09-02 KR KR1019997001757A patent/KR20000068415A/ko not_active Abandoned
- 1997-09-02 NZ NZ333064A patent/NZ333064A/xx unknown
- 1997-09-02 US US09/254,403 patent/US6294674B1/en not_active Expired - Fee Related
- 1997-09-02 WO PCT/US1997/015444 patent/WO1998009957A1/en not_active Ceased
- 1997-09-02 BR BR9712794-9A patent/BR9712794A/pt not_active Application Discontinuation
- 1997-09-02 JP JP51281898A patent/JP2002514180A/ja not_active Abandoned
- 1997-09-02 AU AU41770/97A patent/AU736347B2/en not_active Ceased
- 1997-09-04 HR HR970474A patent/HRP970474B1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US6294674B1 (en) | 2001-09-25 |
| EP0929542A1 (en) | 1999-07-21 |
| KR20000068415A (ko) | 2000-11-25 |
| JP2002514180A (ja) | 2002-05-14 |
| HRP970474A2 (en) | 1998-12-31 |
| AU736347B2 (en) | 2001-07-26 |
| CA2256631A1 (en) | 1998-03-12 |
| HRP970474B1 (en) | 2002-10-31 |
| AU4177097A (en) | 1998-03-26 |
| WO1998009957A1 (en) | 1998-03-12 |
| NZ333064A (en) | 2000-11-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9712794A (pt) | Compostos para e um método de inibição de metaloproteinases matriciais | |
| IL123901A (en) | Sulfonamide inhibitors of matrix metalloproteinases and pharmaceutical compositions comprising them | |
| NO982840L (no) | Aromatiske ketoaminosyrer og deres derivater som inhibitorer for matrisse-metallo-proteinaser | |
| NO972980D0 (no) | Anvendelse av nebivolol som et anti-aterogent middel | |
| FI920771A0 (fi) | Hydroxylamidbaserade kollagenasinhibitorer. | |
| AR009723A1 (es) | Compuesto derivado del acido difenil butirico, su uso para metodos de tratamiento basados en inhibir la metaloproteinasa de matriz, su uso para lafabricacion de composiciones farmaceuticas y su metodo de preparacion | |
| NZ509439A (en) | Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases | |
| BR0013390A (pt) | Compostos de ácido hidroxâmico úteis como inibidores de metaloproteinase de matriz | |
| BR9713921A (pt) | Composto, composição farmacêutica, processo para tógico capaz de ser modulado através da inibição do fator xa | |
| Klawans et al. | Neuroleptic-induced tardive dyskinesias in nonpsychotic patients | |
| BR0307039A (pt) | Compostos, em particular de derivados uréias ou ésteres do ácido haloacetamidobenzóico e sua utilização para o tratamento de doenças parasitárias | |
| BR0309019A (pt) | Associação de um antitrombótico e de aspirina, e sua utilização para o tratamento das doenças aterotrombóticas | |
| Kontny et al. | The effect of taurine and its metabolites on the pathogenic functions of rheumatoid arthritis fibroblast-like synoviocytes | |
| CA2233560A1 (en) | Sulfonamide inhibitors of matrix metalloproteinases | |
| ECSP972244A (es) | Acidos bifenil butiricos y sus derivados como inhibidores de metazoproteinas de matriz | |
| MX9305138A (es) | Lipidos para humidificacion epidermica y reparacion de la funcion de barrera. | |
| ECSP003625A (es) | Compuestos de acido hidroxamico utiles como inhibidores de metaloproteinasa de matriz | |
| ES2127133A1 (es) | Utilizacion de derivados 2,5-dihidroxibencenosulfonicos para la fabricacion de medicamentos destinados al tratamiento y a la prevencion de la enfermedad de alzheimer. | |
| NO921691L (no) | Farmasoeytisk preparat |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE DE ACORDO COM ART. 36 DA LPI |